Total planned funding: $504,446,539
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $167,619,590 |
Zambia | $81,478,901 |
Mozambique | $63,230,004 |
Vietnam | $27,026,613 |
Kenya | $25,641,894 |
Tanzania | $20,676,259 |
Rwanda | $12,837,553 |
South Africa | $12,327,492 |
Botswana | $12,059,397 |
Haiti | $9,230,713 |
Burundi | $8,390,534 |
Côte d'Ivoire | $7,130,330 |
India | $6,523,654 |
Papua New Guinea | $6,189,195 |
Cambodia | $5,250,000 |
Indonesia | $5,176,155 |
Ethiopia | $3,801,603 |
Asia Regional Program | $3,654,954 |
Democratic Republic of the Congo | $3,640,000 |
Uganda | $3,478,804 |
South Sudan | $2,751,916 |
Ghana | $2,750,000 |
Caribbean Region | $2,717,206 |
Malawi | $2,310,000 |
Central America Region | $1,646,143 |
China | $1,500,000 |
Eswatini | $1,333,737 |
Namibia | $1,210,293 |
Angola | $1,085,000 |
Cameroon | $700,000 |
Dominican Republic | $500,000 |
Central Asia Region | $300,000 |
Thailand | $278,599 |
Lesotho | $0 |
Organizational Types
NGO | $496,776,539 |
Implementing Agency | $7,670,000 |
Program Areas
Prevention | $146,514,095 |
Care | $146,007,129 |
Treatment | $137,678,597 |
Governance and Systems | $41,977,332 |
Testing | $32,269,386 |
Budget Codes
HTXS: Treatment: Adult Treatment | $117,834,326 |
HBHC: Care: Adult Care and Support | $74,035,216 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $66,297,916 |
HVOP: Sexual Prevention: Other Sexual Prevention | $49,231,346 |
HKID: Care: Orphans and Vulnerable Children | $45,647,333 |
HVCT: Testing: HIV Testing and Counseling | $32,269,386 |
HLAB: Laboratory Infrastructure | $17,243,284 |
PDTX: Treatment: Pediatric Treatment | $16,420,987 |
HVTB: Care: TB/HIV | $15,157,963 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $14,340,020 |
OHSS: Health Systems Strengthening | $12,537,783 |
HVSI: Strategic Information | $12,196,265 |
PDCS: Care: Pediatric Care and Support | $11,166,617 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $8,346,216 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $7,561,528 |
HTXD: Treatment: ARV Drugs | $3,423,284 |
HMIN: Biomedical Prevention: Injection Safety | $578,324 |
HMBL: Biomedical Prevention: Blood Safety | $158,745 |
Top Partner Programs
FHI 360:
$504,446,539
View countries